Related references
Note: Only part of the references are listed.Targeting the extrinsic apoptosis pathway in cancer
Avi Ashkenazi
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
To kill a tumor cell: the potential of proapoptotic receptor agonists
Avi Ashkenazi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway
I. Verbrugge et al.
ONCOGENE (2008)
Small-molecule XIAP antagonist restores caspase-9-mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells
Saskia A. G. M. Cillessen et al.
BLOOD (2008)
The inhibitor of apoptosis proteins as therapeutic targets in cancer
Domagoj Vucic et al.
CLINICAL CANCER RESEARCH (2007)
Sensitization of pancreatic carcinoma cells for γ-irradiation-induced apoptosis by XIAP inhibition
S. Giagkousiklidis et al.
ONCOGENE (2007)
A phase I pharmacokinetic and pharmacodynamic study of AMG 479, a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R), in advanced solid tumors
A. W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells
M. Vogler et al.
ONCOGENE (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia
Mohammad Hafez et al.
HEMATOLOGY (2007)
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Brendan P. Eckelman et al.
EMBO REPORTS (2006)
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy
Esther H. J. Wissink et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Targeting XIAP for the treatment of malignancy
AD Schimmer et al.
CELL DEATH AND DIFFERENTIATION (2006)
Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity
M Vogler et al.
ONCOGENE (2005)
Apoptosis-based therapies for hematologic malignancies
JC Reed et al.
BLOOD (2005)
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells
A Nencioni et al.
CLINICAL CANCER RESEARCH (2005)
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
BZ Carter et al.
BLOOD (2005)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer
TK Oost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Upstream regulatory role for XIAP in receptor-mediated apoptosis
JC Wilkinson et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The inhibitor of apoptosis protein family and its antagonists in acute leukemias
A Wrzesien-Kus et al.
APOPTOSIS (2004)
High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de Novo acute myeloid leukemia
I Tamm et al.
CLINICAL CANCER RESEARCH (2004)
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem et al.
BLOOD (2004)
A novel method for the combined flow cytometric analysis of cell cycle and cytochrome c release
A Mohr et al.
CELL DEATH AND DIFFERENTIATION (2004)
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
AD Schimmer et al.
CANCER CELL (2004)
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB
H Ehrhardt et al.
ONCOGENE (2003)
Apoptosis in hematological disorders
KM Debatin et al.
SEMINARS IN CANCER BIOLOGY (2003)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
A Ashkenazi
NATURE REVIEWS CANCER (2002)
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
S Fulda et al.
ONCOGENE (2002)
Regulating cysteine protease activity: Essential role of protease inhibitors as guardians and regulators
B Turk et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
A Prokop et al.
LEUKEMIA (2000)
Share Paper
